APP and metabolic dysfunction-associated steatotic liver disease: To assess the impact of hepatic steatosis on APP-processing gene expression, we divided the mRNA expression of liver samples from MASLD patients according to their histological steatosis grade, thereby excluding samples with fibrosis.